Small Fiber Neuropathy Biopsy

Board-certified Pain Specialists

Small Fiber Neuropathy Biopsy in Chalfont & Quakertown, PA

The small fiber neuropathy biopsy is performed help patients who are experiencing symptoms such as:

✅ Numbness or reduced sensation in the feet, legs, or hands
✅ Burning pain or a "pins and needles" sensation, especially at night
✅ Tingling that travels from the feet upward into the legs
✅ Symptoms that worsen with heat or at rest

Request An Appointment

Common Causes of Small Fiber Neuropathy

Because small fiber neuropathy is caused by damage to the smallest sensory nerve fibers, almost any condition that affects the peripheral nervous system can be responsible. In many patients, however, one or more of the following underlying causes can be identified through targeted follow-up testing after the biopsy confirms the diagnosis:

✅ Diabetes and prediabetes
✅ Autoimmune disorders
✅ Thyroid disease
✅ Vitamin B12 deficiency
✅ Celiac disease and gluten sensitivity
✅ Genetic mutations
✅ Idiopathic SFN

Schedule Your Consultation Today

Understanding Small Fiber Neuropathy

The small fiber neuropathy biopsy is a diagnostic tool to understand SFN. Small fiber neuropathy (SFN) affects the smallest nerve fibers in the body. These tiny, unmyelinated fibers are responsible for transmitting pain signals and regulating autonomic functions such as temperature regulation and sweating. When these fibers degenerate or become damaged, the result is often a burning, tingling, or numbing sensation, most commonly starting in the feet and gradually working its way upward.

What makes small fiber neuropathy particularly difficult to diagnose is that it does not show up on standard nerve conduction studies. Those tests, which are the most commonly ordered test for neuropathy, only measure the function of large, myelinated nerve fibers. As a result, many patients with SFN get normal test results for years while symptoms worsen. In many cases, they are told nothing is wrong, even though something clearly is.

Small fiber neuropathy is associated with diabetes, prediabetes, autoimmune disorders, thyroid disease, and certain vitamin deficiencies. However, in some cases, no clear underlying cause is found, which is referred to as idiopathic SFN.

What It Is and How It Works

FAQs

Is the Small Fiber Neuropathy Biopsy Painful?

Most patients report only mild discomfort during the procedure. The skin is numbed with a local anesthetic before the biopsy, the actual punch itself is usually not painful. After the anesthetic wears off, some patients notice minor tenderness at the biopsy site for a day or two. However, in the vast majority of cases, this resolves quickly and without any intervention. According to published safety data from the European Federation of Neurological Societies, non-serious side effects were reported in only 0.19% of approximately 35,000 biopsies performed across 10 specialized laboratories. [Lauria et al., PubMed 20642627]

Can the Biopsy Diagnose Diabetic Neuropathy?

Yes, and this is one of the most important applications of the small fiber neuropathy biopsy. Diabetic peripheral neuropathy is one of the most common causes of small fiber nerve damage. Often, small fibers are affected before the large fibers. In that instance, standard nerve conduction studies can appear normal even in patients with established diabetic neuropathy. The skin biopsy directly measures intraepidermal nerve fiber and can identify nerve damage at a stage when intervention is more likely to make a meaningful difference in long-term outcomes. Furthermore, in patients who have already been diagnosed with diabetes, a biopsy provides objective baseline data to monitor whether the neuropathy is progressing over time.

How Is This Different From a Standard Nerve Biopsy?

A traditional nerve biopsy is typically performed on the sural nerve, is a significantly more invasive procedure that requires a surgical incision and carries a meaningful risk of permanent sensory loss at the biopsy site. The skin punch biopsy used for small fiber neuropathy evaluation is minimally invasive, uses a 3-millimeter tool. This is performed under local anesthetic in the office. Small fiber neuropathy specifically affects the unmyelinated fibers that are richly represented in the skin’s epidermis. A skin biopsy is a targeted test for this condition. It has become the preferred diagnostic method recommended by the European Federation of Neurological Societies and the Peripheral Nerve Society.

Who Should Consider Getting a Small Fiber Neuropathy Biopsy?

This biopsy is most appropriate for patients who have ongoing symptoms of burning, tingling, numbness, or pain in the feet or legs. Additionally, patients with diabetes, prediabetes, or other conditions known to affect small nerve fibers may consider this test. Patients who have been told their symptoms are idiopathic, meaning there is no known cause, are also strong candidates. A skin biopsy may identify objective nerve fiber loss even when other evaluations have been inconclusive.

Why Standard Nerve Tests Miss Small Fiber Neuropathy

Standard nerve conduction studies measure the speed and strength of electrical signals traveling through large, myelinated nerve fibers. These are the thick nerve fibers that carry motor signals and touch sensation. Small fiber neuropathy, by contrast, affects the thin, unmyelinated fibers responsible for pain and temperature. Because those fibers are too small to generate a detectable electrical signal, they are essentially invisible to standard nerve conduction testing.

Furthermore, quantitative sensory testing measures a patient’s subjective response to heat and cold stimuli. This is heavily dependent on patient cooperation and does not differentiate between peripheral and central nervous system involvement. As a result, it is not considered a standalone diagnostic standard. Skin biopsy provides an objective, quantitative measure of nerve fiber density.

Research insight: Skin biopsy with intraepidermal nerve fiber density evaluation has sensitivity of 78 to 92% and specificity of 65 to 90% for diagnosing small fiber neuropathy, making it the most accurate diagnostic tool currently available for this condition. [Gasparotti et al., PMC7554909; Lauria et al., EFNS/PNS Guidelines, PubMed 20642627]

What to Expect

Before the procedure: No special preparation is required. Patients should wear comfortable clothing that allows easy access to the lower leg and ankle area.
During the procedure: A small area of skin is cleaned and numbed with a local anesthetic. A 3-millimeter punch tool is then used to take a tiny skin sample, typically at the distal leg, approximately 10 centimeters above the ankle. The entire process takes only a few minutes, and patients report minimal discomfort.
After the procedure: A small bandage is applied. Most patients return to normal activity the same day. The sample is sent to a neuropathology laboratory for staining and quantitative nerve fiber analysis.
Receiving results: Results are typically available within one to two weeks. Once results are returned, our team reviews them with the patient and develops a targeted treatment plan based on the findings.

What Biopsy Results Mean for Your Treatment

Identifying an underlying cause: Once SFN is confirmed, our team conducts a systematic evaluation for conditions that may be driving the nerve fiber loss. That may include diabetes, prediabetes, thyroid dysfunction, vitamin B12 deficiency, autoimmune disorders such as Sjogren’s syndrome, and certain genetic factors. In many instances, treating the underlying condition can slow or stabilize the neuropathy.
Targeted pain management: With a confirmed diagnosis, medications can be prescribed with greater precision. Treatments for neuropathic pain may include certain anticonvulsants, antidepressants used in low doses for pain modulation, or topical agents such as lidocaine or capsaicin cream, all tailored to the patient’s specific presentation.
Neuromodulation referral: For patients with significant neuropathic pain that does not respond to medication, a confirmed SFN diagnosis also supports referral for spinal cord stimulation, which has shown meaningful benefit for chronic neuropathic pain. In fact, this is an important connection between the biopsy and our full scope of pain care at PA Pain & Spine Institute.
Tracking disease progression: Serial skin biopsies over time can monitor whether nerve fiber density is declining, stable, or recovering, providing an objective measure of treatment response that symptom questionnaires alone cannot offer.

SFN Symptoms

Symptoms vary depending on which nerve fibers are affected and how far the damage has progressed:

Burning pain: Most commonly starting in the feet and ankles, often worse at night
Tingling or pins and needles: Frequently described as a persistent “electric” sensation
Numbness: Reduced sensation to touch, temperature, or pain in the affected area
Allodynia: Pain triggered by stimuli that should not be painful, such as light touch or bedsheets
Autonomic symptoms: Excessive sweating, dry skin, or blood pressure changes in more advanced cases

SFN Diagnosis

Clinical examination: Sensory testing for thermal and pain perception at bedside

Diagnostic Testing:

Skin biopsy (IENFD): Gold standard, directly measures intraepidermal nerve fiber density
Nerve conduction studies: Normal in pure SFN, which is why biopsy is necessary
Blood work: Screens for diabetes, thyroid disease, B12 deficiency, autoimmune markers
Quantitative sensory testing: Measures heat and cold detection thresholds as a supplementary tool

Research insight: A retrospective study using skin biopsy with IENFD analysis detected abnormalities in 88.1% of patients with symptoms suggestive of sensory neuropathy but normal nerve conduction studies, compared with only 10% of healthy controls. Skin biopsy was more often abnormal than either clinical examination or quantitative sensory testing in this population. [Larner et al., PubMed 20065802]

Why Choose PA Pain & Spine Institute for Small Fiber Neuropathy Diagnosis?

In-office small fiber neuropathy biopsy performed by our clinical team, with no outside facility required
A comprehensive diagnostic approach combines biopsy results with clinical evaluation and targeted lab work Access to evidence-based neuropathy treatment including medication management, topical agents, and, for appropriate patients, spinal cord stimulation referral
Convenient locations in Chalfont and Quakertown, serving patients throughout Bucks County and the surrounding region
Board-certified pain specialists who specialize in the full diagnostic and treatment spectrum of neuropathic pain conditions

Request an Appointment

Take the Next Step

If you have been living with unexplained numbness, tingling, or burning in your feet or legs, and prior testing has not given you a clear answer, the small fiber neuropathy biopsy may be the diagnostic step you have been missing. At PA Pain & Spine Institute, our specialists in Chalfont and Quakertown are ready to help you get to the root cause. Schedule a consultation to:

Receive a thorough clinical evaluation and symptom review
Undergo in-office small fiber neuropathy biopsy if clinically appropriate
Identify any underlying conditions driving your nerve damage
Develop a targeted, evidence-based treatment plan tailored to your diagnosis

References

Larner AJ, et al. Skin biopsy for diagnosis of small fiber neuropathy: a critically appraised topic. Muscle & Nerve. 2010. PubMed PMID: 20065802.
Lauria G, et al. Small fiber neuropathy: is skin biopsy the holy grail? European Journal of Neurology. 2012. PubMed PMID: 22570215.
Lauria G, Merkies ISJ, Faber CG. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. European Journal of Neurology. 2010. PubMed PMID: 20642627.
Terkelsen AJ, et al. The diagnostic challenge of small fibre neuropathy: clinical presentations, evaluations, and causes. Lancet Neurology. 2017;16(11):934-944.
Gasparotti R, et al. A systematic review of the diagnostic methods of small fiber neuropathies in rehabilitation. International Journal of Environmental Research and Public Health. 2020. PMC7554909.

The information on this page is for general educational purposes only and does not constitute medical advice. Treatment recommendations are based on individual clinical evaluation. Individual results may vary, and no specific outcomes are guaranteed. This content does not create a provider-patient relationship.